New York, NY -- (SBWIRE) -- 12/13/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Northwest Biotherapeutics, Inc (NASDAQ:NWBO), Eldorado Gold Corp (USA) (NYSE:EGO), MannKind Corporation (NASDAQ:MNKD), Wi-LAN Inc (TSE:WIN)
Northwest Biotherapeutics, Inc (NASDAQ:NWBO) showed a volume of 5.95 million shares by the end of last trade whereas the average volume of the stock remained 12.3.6 million shares. The stock opened the session at $5.31 but then moved to $5.19. At that price, the stock showed a negative performance of -1.89%. Office Depot, Inc. (Office Depot) is a global supplier of office products and services. The Company operates in three business segments: North American Retail Division, North American Business Solutions Division and International Division. The Company’s North American Retail Division sells a range of merchandise through its chain of office supply stores throughout the United States. Its North American Business Solutions Division sells nationally branded and its own brand office supplies, technology products, furniture and services.
Will NWBO Get Buyers Even After The Recent Rally? Find Out Here
Eldorado Gold Corp (USA) (NYSE:EGO) opened the session at $5.55 and closed the session at $5.60. The stock showed a negative performance of -1.58% in previous trading session. Eldorado Gold Corporation (Eldorado) is a gold exploration, development, mining and production company. The Company owns and operates mines worldwide. As of December 31, 2011, the Company had exploration and development projects in Turkey, China, Greece and Brazil. The Company operates the Kisladag gold mine in Turkey;
Has EGO Found The Bottom And Ready To Gain Momentum? Find Out Here
MannKind Corporation (NASDAQ:MNKD) opened the session at $4.85 and closed the session at $4.96. The stock showed a positive performance of 3.12% in previous trading session. Traded with volume of 5.64 million shares in the prior session and the average volume of the stock remained 4.59 million shares. The beta of the stock remained 1.87. MannKind Corporation (MannKind) is a development-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapeutic products for diseases such as diabetes and cancer.
Why Should Investors Buy MNKD After The Recent Gain? Just Go Here and Find Out
Wi-LAN Inc (TSE:WIN) traded with volume of 731,853.00 shares in the prior session and the average volume of the stock remained 604,735.00 shares. The beta of the stock remained 0.88. WiLAN Inc. (WiLAN), is a licensing company. WiLAN develops, acquires, and licenses a range of intellectual property that drives products in communications and consumer electronics markets. Through both internal research and development and acquisitions from third parties, the Company has acquired intellectual property in the form of patents and patent applications in many countries that it has licensed to more than 255 companies in telecommunications markets around the world.
Is WIN a Solid Investment at These Levels? Read This Report For Details
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)